Cancer Cell
Volume 13, Issue 1, 8 January 2008, Pages 48-57
Journal home page for Cancer Cell

Article
MicroRNA Signature Predicts Survival and Relapse in Lung Cancer

https://doi.org/10.1016/j.ccr.2007.12.008Get rights and content
Under an Elsevier user license
open archive

Summary

We investigated whether microRNA expression profiles can predict clinical outcome of NSCLC patients. Using real-time RT-PCR, we obtained microRNA expressions in 112 NSCLC patients, which were divided into the training and testing sets. Using Cox regression and risk-score analysis, we identified a five-microRNA signature for the prediction of treatment outcome of NSCLC in the training set. This microRNA signature was validated by the testing set and an independent cohort. Patients with high-risk scores in their microRNA signatures had poor overall and disease-free survivals compared to the low-risk-score patients. This microRNA signature is an independent predictor of the cancer relapse and survival of NSCLC patients.

CELLCYCLE

Cited by (0)

18

These authors contributed equally to this work.